Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Invigor Medical vs LVNG RX

Invigor Medical
Graded #15

Higher grade

vs+23.599999999999994
LVNG RX
Graded #272

Lower grade

The verdict

Invigor Medical takes it — 86.1/100 to 62.5/100.

Invigor Medical grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. An established pharmacy operator with steady mid-market pricing and a broad catalog.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueInvigor Medical +20
84
64
Dose & formulationInvigor Medical +20
84
64
Clinical oversightInvigor Medical +32
88
56
Labs & monitoringInvigor Medical +24
86
62
FulfillmentInvigor Medical +19
88
69
Contract termsInvigor Medical +29
90
61
Invigor Medical · left barLVNG RX · right bar

The numbers

MetricInvigor MedicalLVNG RX
WeighScore86.1/10062.5/100
GradeBC
Scorecard rank#15#272
Semaglutide$199/mo$149/mo (starting dose, compounded)
Tirzepatide$339/mo$249/mo (microdose tier, starting dose, compounded)
CoverageNot disclosedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Invigor Medical

Graded #15 · B

Strengths

  • Mid-market pricing on both molecules
  • Long-running operator

Where it loses points

  • No explicit states list
  • Compounded only
LVNG RX

Graded #272 · C

Strengths

  • One bundled price covers the provider visit, prescription, shipping and ongoing check-ins, with zero consultation charges
  • States you are charged nothing if a provider does not approve you for treatment
  • Promises no dose-change surcharges — 'the price we quote is the price you pay, period'
  • Semaglutide from $149/mo is competitive against the wider compounded market
  • Offers a lower-dose GLP-1 microdose program alongside standard semaglutide and tirzepatide

Where it loses points

  • Displays a Trustpilot 'Rated Excellent 4.8 / 5' badge, but no Trustpilot profile exists for the domain or the brand
  • Also claims '4.9 based on 300+ Google reviews'; no Google listing for the business could be located
  • Its own homepage figures conflict — '10k+' members in the hero versus '1,743+ patients supported' in the counters below
  • The actual plan price is confirmed only after provider review, and the three treatment pages publish no prices at all
  • No compounding pharmacy, medical group or individual clinician is named anywhere on the site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard